2023 CIMT Annual Meeting Poster Presentation
- Kellyann Zuzulo
- Sep 5, 2023
- 1 min read
YB-200, a novel IgG1 antibody targeting CEACAM1/5, induces complete response in syngeneic liver Hepa1-6 tumor-bearing mice and modulates the immune response
Download full poster below.
Comments